Author

Simeon Babarinde

Scripps Research InstituteORCID 0000-0001-5603-4769Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:bacteria (other)· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Ian A. WilsoniD· 2 shared Adrianna M. TurneriD· 1 shared Alireza Rahimi· 1 shared Althea Hansel-HarrisiD· 1 shared Amal Gebara-LambiD· 1 shared Anil K. Sen GuptaiD· 1 shared Anshul Chaudhary· 1 shared Appaso Mahadev JadhaviD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Ian A. WilsonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintOct 1, 2026

Pan-Coronavirus Protease Engagement and Differentiated Pharmacology of Antiviral Candidate CMX990

N. G. R. Dayan Elshan, Karen C. Wolff, Laura Riva…·Arnab K. Chatterjee

This study evaluates CMX990, a coronavirus Mpro inhibitor, showing broad antiviral activity against multiple coronaviruses and superior pharmacologic properties compared to existing inhibitors.

DOI 10.64898/2026.09.29.755428

humanexperimental assay

𝕏 PostBluesky

MicrobiologyNature CommunicationsPeer-reviewedJun 15, 2026

Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium

Kyong Tkhe Fam, Pavan Kumar Chodisetti, Zifei Wang…·Howard C. Hang

This study shows that inhibiting SagA, a peptidoglycan hydrolase, increases vancomycin susceptibility in VREfm through both genetic and pharmacological approaches.

1 citation

bacteria (other)proteomics

𝕏 PostBluesky